Gen Digital Inc (GEN) concluded trading on Thursday at a closing price of $24.26, with 5.3 million shares of worth about $128.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.49% during that period and on April 10, 2025 the price saw a loss of about -4.53%. Currently the company’s common shares owned by public are about 616.00M shares, out of which, 558.04M shares are available for trading.
Stock saw a price change of -6.69% in past 5 days and over the past one month there was a price change of -9.14%. Year-to-date (YTD), GEN shares are showing a performance of -11.40% which increased to 7.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $19.58 but also hit the highest price of $31.72 during that period. The average intraday trading volume for Gen Digital Inc shares is 4.00 million. The stock is currently trading -8.26% below its 20-day simple moving average (SMA20), while that difference is down -10.28% for SMA50 and it goes to -10.57% lower than SMA200.
Gen Digital Inc (NASDAQ: GEN) currently have 616.00M outstanding shares and institutions hold larger chunk of about 84.33% of that.
The stock has a current market capitalization of $14.95B and its 3Y-monthly beta is at 1.00. PE ratio of stock for trailing 12 months is 23.95, while it has posted earnings per share of $1.01 in the same period. Its PEG reads 2.20 and has Quick Ratio of 0.35 while making debt-to-equity ratio of 3.97. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEN, volatility over the week remained 7.71% while standing at 3.64% over the month.
Stock’s fiscal year EPS is expected to rise by 12.92% while it is estimated to increase by 9.86% in next year. EPS is likely to shrink at an annualized rate of 10.88% for next 5-years, compared to annual growth of 81.21% made by the stock over the past 5-years.
Coverage by UBS stated Gen Digital Inc (GEN) stock as a Buy in their note to investors on December 04, 2024, suggesting a price target of $36 for the stock. On October 24, 2024, Wells Fargo Initiated their recommendations, while on June 07, 2024, Morgan Stanley Downgrade their ratings for the stock with a price target of $27. Stock get an Equal weight rating from Barclays on April 11, 2024.